angiotensin ii has been researched along with oridonin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, W; Fan, D; Huang, SH; Ma, ZG; Tang, QZ; Wan, CX; Wang, HB; Wu, HM; Wu, QQ; Xu, M | 1 |
| Dai, S; Hong, X; Huang, W; Liang, X; Lin, J; Lin, S; Wang, W; Ye, B | 1 |
2 other study(ies) available for angiotensin ii and oridonin
| Article | Year |
|---|---|
Oridonin protects against cardiac hypertrophy by promoting P21-related autophagy.
Topics: Angiotensin II; Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Autophagy; Cardiomegaly; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Diterpenes, Kaurane; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Myocytes, Cardiac; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; RNA, Small Interfering | 2019 |
Oridonin Relieves Angiotensin II-Induced Cardiac Remodeling via Inhibiting GSDMD-Mediated Inflammation.
Topics: Angiotensin II; Animals; Diterpenes, Kaurane; Inflammation; Intracellular Signaling Peptides and Proteins; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Phosphate-Binding Proteins; Pore Forming Cytotoxic Proteins; Rats; Ventricular Remodeling | 2022 |